Related briefings

Digital Therapeutics – Evolution and entry into mainstream healthcare

Research undertaken by DLA Piper’s Life Sciences practice in conjunction with The Lawyer seeks to understand the current developments in the field of digital therapeutics, looking at key questions that need to be addressed if these products are to become mainstream components of health systems across the world.

Latest Briefings

10 stumbling blocks in a business exit

Every business exit is different and a seller’s requirements will vary depending on the nature of their target business, the parties involved and the wider commercial climate. Even so, common issues crop up regularly.

Recommended

DLA Piper

DLA rescues crisis simulation service thwarted by Covid-19

DLA Piper has re-imagined a new crisis simulation training service that cost over £100,000 to deliver, after its launch was put in doubt due to the outbreak of coronavirus. The training service, called “DLA Piper Project Simulator”, was inspired by Carillion’s liquidation in 2017 and was one of the first products stemming out of the […]

Gateley boosts borrowing capabilities by £20m

Listed law firm Gateley is anticipating a boost in revenue for the current financial year, forecasting that turnover will be no less than £108m for 2020; an increase of £4.5m. This is despite a series of recent measures put in place by the firm, including an expansion of its working capital facilities of up to […]

Find legal roles

Make your next move with The Lawyer Careers. Search and apply for thousands of vacancies, or receive email alerts for new roles when they go live. Whether you're looking at private practice, in-house legal or an exciting business support role, you'll find your future here.

Search vacancies